Insights

Company diagnostic

Semiconductors

INTC

Intel

Intel Foundry lost $10.3B while Intel Products earned $12.7B; gross margin of 34.8% trails the 53.1% semiconductor median, an observed gap of $7.9B.

Why now

In the news

Intel reported third-quarter 2026 revenue of $16.5 billion on October 29, 2026, up 21%, with Intel Foundry revenue up 58% to $6.7 billion and a foundry operating loss of $1.85 billion, per the company's results release.

Business health score

38

Out of 100

Addressable estimate

$3,171.2M addressable estimate (observed gap $7,928M)

Revenue

$52,853M (FY2025)

Operating margin

-4.2% (-3.3% excluding the $494M impairment)

As reported

Filing

Form 10-K, fiscal year 2025 (year ended December 27, 2025)

Run

November 10, 2026

Processing

8

minutes

Output

35

-page PDF and Excel model

Data quality

90

Point-in-time analysis from the filing and run date shown. The news context reflects reporting available on that date, and this page is not updated as events move on.

Score by dimension

Financial health

15

Growth potential

Strategic readiness

Market position

Innovation and digital

Operational efficiency

65

First 100-day action

Run a zero-based review of Intel Foundry economics, covering per-wafer manufacturing cost, yield by process node and the external customer pipeline.

How it compares

Against the median of the report's benchmark peer set

  • Revenue growth: -0.5% vs peer median 15.3% (Well behind median)
  • Gross margin: 34.8% vs peer median 53.1% (Well behind median)
  • Operating margin: -4.2% vs peer median 21.1% (Well behind median)
  • EBITDA margin: 18% vs peer median 29.8% (Well behind median)
  • Net margin: -0.5% vs peer median 16.5% (Well behind median)
  • SG&A, % of revenue: 8.7% vs peer median 10.2% (Better than median)
  • R&D, % of revenue: 26.1% vs peer median 18.2% (Top quartile)
  • Return on assets: -0.1% vs peer median 8.2% (Well behind median)
  • Debt to equity: 0.41x vs peer median 0.35x (Behind median)
  • Asset turnover: 0.25x vs peer median 0.47x (Well behind median)
  • Inventory turnover: 2.97x vs peer median 2.63x (Better than median)
  • Days inventory outstanding: 123 days vs peer median 139 days (Better than median)
  • Days payable outstanding: 104.6 days vs peer median 46 days (Top quartile)

Top three levers

Lever 1

Intel Foundry yield optimization and cost alignment

High complexity, 24 months

Why this lever

Gross margin of 34.8% trails the 53.1% semiconductor median by 18.3 points, an observed gap of $7,928M. The report ties it to Intel Foundry's $10.3B operating loss on $17.8B of segment revenue, fixed manufacturing overhead, node-transition costs and $11.7B of depreciation, and treats 40% of the gap as addressable, an estimate to be tested.

Size

$3,171.2M

Observed gap $7,928M

Lever 2

Capital asset efficiency and fab joint-venture structuring

Low complexity, 12 months

Why this lever

Asset turnover of 0.25x trails the 0.47x median, with capital expenditure of $14.6B, 27.7% of revenue, on $211.4B of total assets. The report points to joint-venture structures for fab capacity and to aligning expansion with committed customers, and does not size the lever.

Size

Directional

Not sized in the report

Lever 3

R&D productivity and portfolio optimization

Medium complexity, 12 months

Why this lever

R&D of $13.8B is 26.1% of revenue against an 18.2% median, while revenue fell 0.5% against a 15.3% median. The report points to reallocating R&D toward server CPUs and AI accelerators, and does not size the lever.

Size

Directional

Not sized in the report

Questions for management

  1. What are the specific 18A process node yield rates and cost-per-wafer targets for 2027, and how do they compare to TSMC's 3nm equivalent? What customer design wins are committed or in advanced discussions for 18A production ramps?
  2. How does Intel plan to defend server CPU market share against AMD and emerging Arm-based alternatives? What is the revenue and gross margin trajectory for Xeon server CPUs over the next 3 years?
  3. What is the addressable market opportunity for Gaudi accelerators, and what is the realistic market share target by 2027? How will Intel overcome NVIDIA's CUDA ecosystem lock-in and hyperscaler relationships?

Summary

Intel closed fiscal 2025 with revenue of $52,853M, down 0.5%, and an operating loss of $2.2B, a -4.2% margin. The two segments tell different stories: Intel Foundry lost $10.3B on $17.8B of revenue, while Intel Products earned $12.7B of operating income on $49.1B. Capital expenditure of $14.6B left free cash flow at -$4,949M.

The net loss narrowed from $18,756M in FY2024 to $267M. The improvement came from outside operations: a $5,553M gain on the Altera divestiture is in non-operating income, while operations still lost money. Against North American semiconductor peers, gross margin of 34.8% trails the 53.1% median, an observed gap of $7,928M, of which the report treats $3,171.2M as addressable and labels the share an estimate. R&D intensity and payables are top quartile.

The balance sheet is less stretched than gross debt suggests. Total debt of $46,585M is offset by $14,265M of cash and $23,151M of short-term investments, so net debt to EBITDA is about 1.0x. The first 100-day move is a zero-based review of foundry economics, and the questions for management cover 18A yields and customer wins, server CPU share and the AI accelerator plan.

What this report does not cover

Four of six health dimensions are not rated, because fewer than two benchmarked metrics were available for each. Intel sells receivables on a non-recourse basis, so DSO is not benchmarked. The $494M impairment has no company-adjusted operating figure, so margins are scored on the reported basis with the figure excluding the impairment shown beside them. Third-quarter 2026 results come from the company's release and are not reflected in the FY2025 figures.

More company diagnostics and category insights

All insights

Get the full report

PDF reportExcel model

No account needed.

Run this on a company you are assessing

Request a free analysis

This analysis is generated by the ValueChaser platform from the company's public Form 10-K, ValueChaser benchmarks and public market intelligence. It is not investment advice, does not reflect any non-public information and is not affiliated with or endorsed by the company.

Run a company diagnostic on your own data

ValueChaser is not a portfolio-management, PMO or source-to-pay platform. It is the diagnostic layer that turns financial and procurement data into quantified value-creation opportunities. Analysis is generated in minutes, with completed client diagnostics available within 24 hours.